ReviewCancers2020

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review.

Frederik van Delft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.